Kairos Pharma, Ltd. (KAPA) is a publicly traded Healthcare sector company. As of November 3, 2026, KAPA trades at $0.50 with a market cap of $1.79M and a P/E ratio of -3.19. KAPA moved +5.60% today. Year to date, KAPA is -90.56%; over the trailing twelve months it is -93.91%. Its 52-week range spans $0.48 to $14.77. Rallies surfaces KAPA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for KAPA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $0.50 |
| Market Cap | $1.79M |
| P/E Ratio | -3.19 |
| EPS | $-0.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.77 |
| 52-Week Low | $0.48 |
| Volume | 173.66K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-5.45M |
| Gross Margin | 0.00% |
KAPA analyst coverage data. Average price target: $0.00.